Calamos Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56,295
| Closed | -$7.44M | – | 893 |
|
|
2024
Q4 | $7.44M | Hold |
56,295
| – | – | 0.03% | 434 |
|
|
2024
Q3 | $8.2M | Hold |
56,295
| – | – | 0.04% | 434 |
|
|
2024
Q2 | $7.73M | Hold |
56,295
| – | – | 0.03% | 437 |
|
|
2024
Q1 | $7.72M | Hold |
56,295
| – | – | 0.04% | 436 |
|
|
2023
Q4 | $7.65M | Buy |
+56,295
| New | +$7.65M | 0.04% | 432 |
|
|
2020
Q2 | – | Sell |
-60,856
| Closed | -$6.56M | – | 721 |
|
|
2020
Q1 | $6.56M | Sell |
60,856
-779
| -1% | -$83.9K | 0.05% | 349 |
|
|
2019
Q4 | $7.43M | Buy |
61,635
+27,905
| +83% | +$3.36M | 0.04% | 405 |
|
|
2019
Q3 | $3.36M | Sell |
33,730
-46,945
| -58% | -$4.67M | 0.02% | 528 |
|
|
2019
Q2 | $8.8M | Sell |
80,675
-470
| -0.6% | -$51.3K | 0.05% | 337 |
|
|
2019
Q1 | $9.07M | Buy |
81,145
+27,340
| +51% | +$3.06M | 0.06% | 308 |
|
|
2018
Q4 | $5.19M | Buy |
53,805
+865
| +2% | +$83.4K | 0.03% | 399 |
|
|
2018
Q3 | $6.46M | Sell |
52,940
-114,115
| -68% | -$13.9M | 0.04% | 370 |
|
|
2018
Q2 | $18.3M | Buy |
167,055
+235
| +0.1% | +$25.8K | 0.11% | 214 |
|
|
2018
Q1 | $17.8M | Sell |
166,820
-24,385
| -13% | -$2.6M | 0.12% | 218 |
|
|
2017
Q4 | $20.4M | Hold |
191,205
| – | – | 0.1% | 183 |
|
|
2017
Q3 | $21.3M | Buy |
191,205
+69,195
| +57% | +$7.69M | 0.16% | 185 |
|
|
2017
Q2 | $12.6M | Hold |
122,010
| – | – | 0.09% | 238 |
|
|
2017
Q1 | $11.9M | Buy |
+122,010
| New | +$11.9M | 0.09% | 259 |
|